Everyone Says We Must Control Exorbitant Drug Prices. So, Why Don’t We?
Any momentum to address prescription drug costs has been lost amid rancorous debates over replacing Obamacare and stalled by roadblocks erected via lobbying and industry cash.
The independent source for health policy research, polling, and news.
801 - 820 of 986 Results
Any momentum to address prescription drug costs has been lost amid rancorous debates over replacing Obamacare and stalled by roadblocks erected via lobbying and industry cash.
The measure proposed by Sens. Lindsey Graham (R-S.C.) and Bill Cassidy (R-La.) would disrupt the existing health system more than any of the measures considered so far this year, according to supporters and critics.
In this Facebook Live, KHN's Julie Rovner talks to Bruce Lesley, president of First Focus, about the current state of play on CHIP reauthorization.
The Affordable Care Act gave some Americans the chance to strike out on their own in new business ventures because they didn't have to worry about keeping a job just for health insurance. But the repeal-and-replace efforts reignited this week create uncertainty about whether they can count on that insurance option in the future.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss Senate Republicans’ last-ditch effort to upend the Affordable Care Act ahead of a Sept. 30 deadline.
Republicans are making a concerted push to unite around a bill sponsored by Sens. Lindsey Graham and Bill Cassidy that would gut major provisions of the federal health law.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Stephanie Armour of The Wall Street Journal discuss Democratic, Republican and bipartisan health proposals all being pursued in Congress, including the latest version of Sen. Bernie Sanders’ (I-Vt.) “Medicare-for-All” proposal. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
The Senate health committee is putting aside partisan bickering this month to seek a legislative remedy to a possible spike in Obamacare premiums this fall.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Mary Agnes Carey of Kaiser Health News discuss the return of Congress and bipartisan efforts to shore up the individual health insurance market for 2018, as well as renew the Children’s Health Insurance Program.
State leaders tell senators that federal dollars are needed this fall to keep insurers participating in Obamacare next year and prevent big hikes in premiums.
The federal health law includes a provision that allows states to alter some of its rules if they can think of a better way to provide health care to their residents, but it’s not clear how far outside the box states can go.
The Senate Finance Committee begins hearings Thursday on the program, which provides coverage to more than 9 million children and is up for renewal on Sept. 30.
Making needed fixes to Obamacare before next year may be more difficult — and expensive — than Senate leaders think, state insurance commissioners suggested at a Senate hearing Wednesday.
The Deferred Action for Childhood Arrivals program made it possible for young adults who came into the country illegally as children to get jobs with insurance and, in some states including California, Medicaid. Now that coverage is in peril.
The fate of the Affordable Care Act’s individual insurance marketplaces remains in play as state insurance commissioners take a central role in the debate.
Innate Immunotherapeutics, the Australian biotech firm whose largest shareholder is Buffalo, N.Y.-area congressman Chris Collins, said it expects to close after its multiple sclerosis drug failed in trials.
As lawmakers look for ways to stabilize the health law marketplaces, a number of ideas — such as expanding who can “buy in” to Medicare and Medicaid or pushing young adults off their parents’ plans into the marketplaces — might come into play.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Margot Sanger-Katz of The New York Times discuss the continuing efforts in Congress to “repeal and replace” the Affordable Care Act, upcoming open enrollment for individual insurance and Congress’ long health care to-do list for September.
Politicians who tried to take health care benefits from their voters may face political consequences as constituents come to understand what’s at stake — in a way they didn’t a few months ago.
In this episode of “What the Health?” Mary Agnes Carey of Kaiser Health News, Sarah Karlin-Smith of Politico, Margot Sanger-Katz of The New York Times and Julie Appleby of Kaiser Health News discuss the recent extension of cost-sharing subsidies for millions of low-income beneficiaries on the Affordable Care Act’s marketplaces and the state of play on Capitol Hill and in the states concerning initiatives to lower prescription drug costs.
© 2026 KFF